Skip to main navigation Skip to search Skip to main content

A Prosepctive, Randomized, Controlled, Multi-Center Study to Establiash the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Requiring Aortic Valve Replacement Who Have Severe, Calcific, Aortic Stenosi

Project: Research

Project Details

StatusActive
Effective start/end date11/14/1611/14/28

Funding

  • Edwards Lifesciences LLC: $845,186.74